B-SMART - Broadly neutralizing antibodies for SaRNA Mediated Antiviral Response Therapy
Award Notice Posted
- Solicitation number
- PHS2025-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Lynntech Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93025C00022 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- College Station, Texas 77845, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, has awarded contract 75N93025C00022 to LYNNTECH INC. for the B-SMART program, which focuses on developing broadly neutralizing antibodies for Self-amplifying RNA (saRNA) Mediated Antiviral Response Therapy. The contract, valued at $599,989, was awarded on August 1, 2025, and was set aside for total small business participation. This initiative appears to be developing advanced therapeutic approaches using saRNA technology combined with broadly neutralizing antibodies to create novel antiviral treatments, representing a cutting-edge approach to infectious disease countermeasures.
Notice text
Awarded contract 75N93025C00022 to LYNNTECH INC. for 599989.00 on 2025-08-01.
Notice history
6 of 10 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity